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Abstract
Telemedicine programs are widely used in respiratory diseases, more often in patients
with  chronic  obstructive  pulmonary diseases  (COPD).  Telemedicine  platforms use
several devices to measure vital signs such as heart rate, respiratory rate, pulsioxime‐
try or blood pressure between others. It is not unusual that patients could do question‐
naires about clinical situation or communicate with their nurses via telephone, video-
calling and/or Skype. The majority of results has been positive, with reduction in the
number of emergency visits,  hospitalizations and noninvasive ventilations. Despite
their promising results, telemedicine programs/platforms are slow to implement. In this
chapter, we reviewed some of the factors related to telemedicine implementation such
as patients’ adherence, impact of telemedicine design and professionals' resistance to
change between others.
Keywords: COPD, eHealth, home telemonitoring, telemedicine, telemedicine plat‐
forms
1. Introduction
Chronic obstructive pulmonary diseases (COPD), asthma and lung transplantation have been,
by far, the respiratory diseases or conditions more studied, in terms of telemedicine. Howev‐
er, the interest of telehealth providers in new areas also related to neurologic conditions, such
as neuromuscular diseases in need of home noninvasive ventilation (NIV) due to chronic
respiratory failure, or sleep-related breathing disorders, has arisen in recent years.
Existing evidence reveals promising results regarding reliability and validity of measures
across all pulmonary conditions, and patients usually show a positive attitude toward telecare
technologies. Other positive effects, for instance, detection of complications, better disease
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control, immediate feedback, and adequate medication use, have also been addressed [1]. Yet,
there is still somewhat decreased adherence within time, possibly secondary to poor health
status, time conflicts, device problems, and lack of ability to operate the system [2]. Further‐
more, there is no solid evidence about the utilization of healthcare resources, as well as cost-
effectiveness, paramount scenarios to advocate in favor of this new way of approaching
chronic respiratory patients.
In the following section, current evidence apropos specific respiratory diseases (COPD,
asthma, lung transplantation, neuromuscular diseases, and SRBD) will be disclosed, focusing
on the positive results, along with the pitfalls found so far.
1.1. Telemedicine
Telemedicine (TM) has several definitions and all of them emphasize the role of telemedicine
to enable the completion of the medical act at distance (Table 1) [3–5]. Norrit et al. define TM
as a scientific area that uses information and communication technologies (ICT) to share
medical information [6]. Thanks to ICT development, TM clinical opportunities are increasing.
The information provided by TM programs can be useful for diagnosis and treatment of several
diseases, as well as for enhancing their follow-up.
Ref Definition
WHO  [3] The delivery of health care services, where distance is a critical factor, by all health care
professionals using information and communication technologies for the exchange of valid
information for diagnosis, treatment and prevention of disease and injuries, research and
evaluation, and for the continuing education of health care providers, all in the interests of
advancing the health of individuals and their communities.
ATA [4] Telemedicine is the use of medical information exchanged from one site to another via electronic
communications to improve a patient’s clinical health status. Telemedicine includes a growing
variety of applications and services using two-way video, email, smart phones, wireless tools,
and other forms of telecommunications technology.
Bashur R  [5] Telemedicine is conceived of as an integrated system of health-care delivery that employs
telecommunications and computer technology as a substitute for face-to-face contact between
provider and client.
WHO: World Health Organization; ATA: American Telemedicine Association, Ref: Reference.
Table 1. Telemedicine’s definitions.
Historically, Dr. Graham Bell performed the first TM experience, when he used the telephone
calling for help when he was sick. Also, in 1923, Sahlgrenska University (Gothenburg) used
the Morse code to provide medical advice. TM programs were funded by the privacy industries
in 1990 for the first time, and in 1993, the first telemedicine symposium was celebrated. Over
50 years, TM has been used for different programs such as: monitored surgeries, remote
assistance in rural zones of Arizona, or vital signs monitoring of astronauts in space, just like
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Bashur et al. demonstrated [7]. In fact, aerospace technology development has been one of the
most important factors in TM evolution. In 1976, the Hermes satellite was put into orbit with
the main objective of improving communications in remote areas of Canada. Since then, the
Western Ontario University has been using it for telemonitoring of vital signs, sharing medical
information between hospitals and, finally, sharing radiographies [8]. Moreover, the National
Aeronautics and Space Administration (NASA) also has used TM to give medical assistance
if a disaster takes place.
Generally speaking, TM applications could be classified into three groups: (a) normal clinical
activity (teleconsult, telediagnosis, teletreatment, etc.), (b) remote assistance, and (c) adminis‐
tration labors and patient management.
1.1.1. Clinical activity
Almost all studies are aimed for telemonitoring patients or sharing medical data, where this
medical act at distance needs a TM platform and a clinical response. We could classify the
clinical response into two groups: synchronic or asynchronic response (Figure 1). The main
difference is the time to response [9]. While in the first group, the clinical response is immediate
and allows performing a live medical act, the second group clinical response is deferred
(minutes or few hours). Asynchronic response is useful in telepatologhy or teleradiology, or
in other telediagnosis programs.
Figure 1. Telemedicine classification.
1.1.2. Remote assistance
In this group, several medical actions are included such as online records for consulting
previous medical charts, establishing a direct communication between patients and physi‐
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cians, or teleconference between primary and specialized care doctors, useful for discussing
difficult cases and take decisions for complex patients (terminal disease, multiple comorbidi‐
ties, social exclusion, impossibility to attend the hospital, etc.).
1.1.3. Patients’ management
Nowadays, patients manage their medical events via Internet more often, and their doctors
can use the same way to give medical recommendations (rehabilitation, nutritional care,
tobacco information, or health life recommendations). Obviously, TM is a helpful tool for
health care personnel as well. In this case, TM is used to access scientific information or as a
type of communication for multicentric and international clinical trials.
1.2. Telemedicine: barriers and benefits
According to the Europe Institute of Technologies findings, only 14.2% of citizens had used
the Internet to solve their health related doubts. The more frequent searches regarding these
issues were: disease description, clinical trials, medical literature, or patients’ disease associ‐
ations (Table 2).
Table 2. Search topics by patients and healthcare professionals.
There are several studies that have showed important barriers for applying TM programs.
Segrelles-Calvo et al. suggested that healthcare policy, lacking studies about economic burden
and cost-effectiveness of TM, no laws regarding the handling of information in TM programs
and the resistance to change “usual medicine conception,” are some causes that explain slow
TM implantation [10]. According to the concept of “resistant to change usual care,” Mira-Solves
et al. presented the results of the ValCrònic program [11], in which authors discussed the causes
to leave a TM program. The main reasons were: (1) difficulty to use the devices, (2) complex
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measures, (3) nonadherence with TM program, (4) technical problems, and (5) caregivers
preferences.
Another important barrier not well studied is the opinion of health professionals toward TM
programs. Telemedicine collects a lot of information and their belief is that TM increases
workload. However, this belief is not displayed in scientific studies. Jódar-Sánchez et al. [12]
showed indeed that a specialized nurse could solve most of the clinical urgencies detected,
where only 8 of 40 cases needed a pneumologist intervention. Similar results were published
by Vitacca et al. [13] reporting that in 63% of alerts, these could be resolved only by a nurse,
and in the rest of them both physician and nurse gave the clinical response. As conclusion, it
seems that there are external factors acting as barriers in the TM implantation, and further
works are required to establish them. Motulsky et al. [14] and Cresswell et al. [15] pooled those
external factors in three groups: (1) healthcare institutions policy, (2) the urge of guidelines
about TM, and (3) the need of specific formation and educational resources.
Telemedicine offers four fundamental benefits [4]:
a. Improved access: Telemedicine has been used to bring healthcare services to patients in
distant locations.
b. Cost efficiencies: Telemedicine reduces the number of hospitalizations and the cost related
to these events. Telemedicine program reduce patient displacement to Hospital and
reduced travel times.
c. Improved quality: Studies have consistently shown that the quality of healthcare services
delivered via telemedicine is as good as those given in traditional in-person consultations.
d. Patient demand: The greatest impact of telemedicine is on the patient, their family and their
community. Telemedicine could reduce travel time and related stresses for the patient.
Almost all studies have shown that patient and caregiver’s satisfaction is very high.
1.3. Telemedicine platforms
In general, there is a common objective in telemedicine programs; however, there are several
platforms in which TM could be offered. Telemedicine platforms are related to ICT. The most
common scheme in telemedicine (Figure 2) is the one that includes devices to measure different
vital signs or questionnaires, in order to perform a teleconsultation or to send educational
resources to patients. Those measures could be made by the patients, anywhere and anytime.
Clinical information is sent to a call center or a health professional by different means (tele‐
phone, Internet, etc.), and the clinical response is made according to all information regarding.
Some of the ICT used in telemedicine platform are as follows:
Videoconference. Possibly this ICT was one of the most important technological advances as a
telemedicine platform. Mahmud et al. [16] made a follow-up platform of patients with chronic
diseases (heart failure, COPD, cerebrovascular disease). In seven cases, the number of emer‐
gency department visits and hospitalizations were reduced, and the authors did not found
complications in the use of the videoconference platform. These results were confirmed in 2000
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by Johnston et al. [17] and by Nakamura et al. [18]. Johnston determined a reduction of 17%
of home visits as well as a 27% reduction of costs in the telemedicine group. Moreover,
Nakamura reported an improvement of daily activities in the telemedicine group. Recent
studies have used videoconference to improve adherence to a telerehabilitation program [19],
to follow-up patients with bipolar disorder [20] or to monitoring tuberculosis therapy com‐
pliance [21], among other topics. According to these studies, in our view the videoconference
is a remarkable technology, facilitating the follow-up of patients to improve their adherence
to treatment.
Figure 2. Telemedicine platform.
Telephone. Mainly, studies have focused in the telephone as a device to follow-up of patients
but Balas et al. [22] described five possible actions that we could also do via telephone: (1)
follow-up, (2) videoconsultation due to interactive telephone, (3) telephonic reminders of
taking a medicine or doing an exercise, (4) calling health professionals if case of clinical
deterioration, and (5) clinical investigation.
E-mail. Email is a rather quick tool for the patients to communicate with health professionals,
making it easier for the latter to perform questionnaires so any given doubt of the patient or
caregiver could be cleared up.
2. Chronic obstructive pulmonary diseases
It is now consensually agreed that an estimated number of 328 million people have COPD
worldwide, that is, 168 million men and 160 million women. Moreover, COPD causes the death
of 2.9 million people annually and it is projected to be the third cause of mortality by 2020 [23].
Mobile Health Technologies - Theories and Applications62
Whereas the three most important factors in individual patients that determine the economic
and social costs of COPD are disease severity, presence of frequent exacerbations of disease
and the presence of comorbidities, which are common (30–57%) in COPD patients [24], the
current short-term and long-term strategies to reduce the burden of COPD comprise the triad
of smoking cessation, minimizing acute exacerbations and management and prevention of
comorbidities [25].
Hence, a high priority should be given to interventions aimed at delaying the progression of
disease, preventing exacerbations and reducing the risk of comorbidities in order to alleviate
the clinical and economic burden of COPD in Western countries [26]. Among these interven‐
tions, telemedicine has shown some promising results although no conclusive evidence has
been accomplished. The effects of telemedicine in COPD have been addressed in previous
systematic reviews [27, 28]; however, their conclusions are not consistent since the types of
tested interventions have been rather heterogeneous. These interventions range from simple
telephone or video interviews to daily telemonitoring of physiological parameters or symp‐
toms data, and that is why comparativeness of one study to the other does not come along
easily.
So far, there is moderate evidence of the benefit of telemedicine in COPD, in terms of increasing
quality of life and reducing hospital admissions. Basically, the problem has been that in
previous years the studies included in systematic reviews were underpowered, had hetero‐
geneous populations and had lack of detailed intervention descriptions and of the care
processes that accompanied telemonitoring [29]. Another issue is the clinical scenario where
patients are usually recruited. For instance, telemedicine can be offered to those patients prone
to exacerbations that are in stable condition [30], or right after admission regardless of the
number of previous exacerbations or FEV1 obstruction severity [31].
Regarding telemonitoring (understood as retrieving periodically clinical data such as oxygen
saturation, heart rate, symptoms, etc.), recent data including randomized clinical trials of good
quality are now available; however, some of them are still underpowered. In terms of hospital
admissions, one of the latest systematic reviews on the matter, which included eight studies
with 486 patients randomized to home telemonitoring or usual care, determined a significant
lower risk of hospitalizations in the telemonitoring group. However, healthcare utilization in
general was similar in both groups, since it was not clear whether the utilization was due to
respiratory events specifically, and the lower range of compliance to telemonitoring reported
by some studies may have influenced the ability of detecting clinical deterioration [32].
Moreover, even between this data retrieved on a daily basis there were different clinical
features measured, which end up inevitability in being quite difficult to integrate quantitative
variables because of missing or noncomparative data. Thus, the extrapolation of these results
to the general population should be carried out with absolute caution. The usual problem with
these systematic reviews is that, due to the heterogeneity of outcomes and the way the studies
have assessed them, it is troublesome to determine the true effect of telemonitoring on COPD
patients. For instance, adding a closer approach to patients with videoconsultations to the
usual telemonitoring, which would be ideal in order to obtain higher rates of compliance or
Telemedicine Programs in Respiratory Diseases
http://dx.doi.org/10.5772/64705
63
reduction of the use of healthcare resources in general, failed to demonstrate differences in
hospital admissions or time to first admission or all-cause hospital admissions [33].
Detection and management of COPD exacerbations in early stages is an important step in order
to reduce hospital admissions and the consequent increase of quality of life and reduction of
health costs in general. So far, telemedicine has proven to be a useful tool to achieve this.
Physical activity, one of the strong mortality predictors in COPD patients, if not the strongest,
has not been properly issued. Although no conclusive evidence of telemedicine benefit exists
on this regard, the use of telehealthcare may lead to increased physical activity level [34]. A
recent study that evaluated the feasibility of a telerehabilitation program compared to a regular
outpatient program, showed an increase of physical activity measured by steps/day in the
telerehabilitation group, with acceptable rates of satisfaction with the service, although no
differences were found when the 6-minute walking test, dyspnea measured by the Medical
Research Council or quality of life measured by the St. George’s Respiratory Questionnaire
were compared [35].
The cost-effectiveness of telemedicine in COPD is yet to be determined. In fact, a recent study
carried out in the United Kingdom, which recruited 3230 patients where both at baseline and
follow-up participants with COPD made up the largest telehealth intervention group, showed
that costs of self-reported service use, combined with telehealth intervention costs, were
greater for the group randomized to telehealth in addition to standard care than for the group
randomized to usual care alone [36]. However, the validity of this conclusion may be biased
for two reasons. First, the trial recruiters had foreknowledge of the allocation groups in many
cases [37], and second, its transferability to other healthcare systems was not taken in consid‐
eration since the trial did not include all community and healthcare resources. Thus, a recent
Danish trial (TeleCare North) will determine the real benefit of telemedicine in COPD in terms
of health-related quality of life and the incremental cost-effectiveness ratio through a large-
scale, pragmatic, cluster-randomized trial with nested economic evaluation [38].
Quality of life, a paramount feature in COPD and a strong predictor of mortality, has been
analyzed irregularly. Once again, the instruments used to determine the health related quality
of life vary greatly among the telemedicine studies (i.e., Chronic Respiratory Disease Ques‐
tionnaire, Chronic Respiratory Questionnaire, St. George’s Respiratory Questionnaire (SGRQ),
Clinical COPD Questionnaire, EURO-QOL-5D Questionnaire, Medical Outcome Study Short-
Form 36 Questionnaire), so comparative data is deficient. Overall, no significant differences
have been found between a home telemonitoring group and the usual care group [32].
The aim of telemedicine toward COPD patients should be to keep this population outside the
hospital or the emergency rooms. Although there is evidence that this aim has been achieved
in some studies, we are still in need of larger clinical trials which include a rigorous cost-
effectiveness analysis in terms of use of healthcare resources separated by respiratory diseases
or not, quality of life, and mortality. Furthermore, a 6- or 12-month follow-up is insufficient to
determine conclusive differences in favor of telemedicine.
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3. Asthma
Asthma is a worldwide disease affecting 300 million of people, and its economic and social
costs are mostly related to emergency visits and hospital admissions. Self-monitoring of
symptoms and peak flow, following a written action plan and attending regular visits to their
physician, have demonstrated to improve asthma control [39], and that is why approaches
through telemedicine have been done to increase its control and follow-up. It has been
hypothesized that providing self-monitoring tools such as easy-to-use handheld electronic
monitoring devices or symptom questionnaires, patients can gain insight into their level of
asthma control which gives them suggestions for subsequent treatment adjustment [40]. This
is why telemedicine for asthma appears to be a promising tool to achieve this so wished for
self-control and management of the disease.
However, there are some pitfalls regarding telemedicine for asthma. If noncomparative data
due to the different sort of interventions is a main issue for COPD, the problem is probably
more serious for asthma. One of the most relevant systematic reviews in the matter included
21 studies, of which nine consisted in telephone calls, two in videoconferences, two in using
the Internet, one in short text messaging, one in a combination of short text and Internet, and
six more using other networked communications. This study demonstrated no improvement
of quality of life and even a nonsignificant increase of emergency room visits in the telemedi‐
cine group, although a significant reduction of hospitalizations was observed [41]. However,
some authors have stated some concerns about these meta-analysis conclusions. First of all,
there were only few examples of a comprehensive telemanagement approach in asthma
(defined as a treatment plan, self-monitoring of lung function by FEV1 and asthma control with
feedback and e-communication with a professional to support this self-management), and
second, patients in the control strategies often received an enhanced form of usual care, which
makes it difficult to draw final conclusions on the effectiveness of telemanagement in asthma
[40]. A more recent meta-analysis of 20 trials involving 10,406 asthmatic patients where
common outcomes employed were healthcare utilization, quality of life and symptoms,
concluded that the median effect of telemedicine was weakly positive, and that there were not
differences between the types of interventions (telemonitoring, routine voice contact or
videoconferencing). But the problem with this positive effect is that a publication bias exists
due to the tendency of more positive results reported in earlier studies, which contained
heterogeneous outcomes measurement and assessment [42].
Regarding cost-effectiveness we are still in need of studies addressing the topic specifically,
situation that withholds the use of telemedicine for asthma unquestionably. Probably the only
evidence of cost-effectiveness of Internet-based self-management compared with usual care,
showed no significant differences during a follow-up of one year. However, this study had
several limitations, acknowledge by the authors. First, the quality adjusted life year estimates
were calculated out of only two measurements throughout one year. Second, patients were
inevitable conscious of the allocated group, which may have influenced their utility ratings.
And third, the economic evaluation was limited to one year only [43]. Regarding a specific
feature of telemedicine, another study showed that telephone consultations led by experienced
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nurses enabled a greater proportion of asthma patients to be reviewed at no additional cost to
the health service, although these findings should not be extrapolated as a thorough cost-
effectiveness analysis, compared to the comprehensive telemanagement as explained before
[44, 45].
Despite the similar moderate evidence either for asthma or COPD, there are some differences
when telehealthcare main purposes are compared between the two diseases. While in COPD
telemedicine aims to reduce exacerbations or their early detection in order to avoid emergency
rooms visits or hospital admissions, in asthma these objectives are usually directed at assuring
a better symptoms self-control and adherence to treatment, considering that undertreatment
is the most common problem in European asthmatic subjects [46], and its usual presentation
at early stages of life. A fitter control of asthma has been reported possibly secondary to the
opportunity of register symptoms continually, thus, the patient obtained a more accurate
picture of his disease severity and complied to treatment with a closer and efficient self-
monitoring. However, this severity awareness led to an increased number of unscheduled
visits and a harmful consumption of inhaled corticosteroids, which increased their adverse
effects [47]. In a similar fashion, another study revealed that 43 patients under a mobile
telephone interactive self-control system and compared with a control group, presented
significantly higher mean daily dosage of either inhaled or systemic corticosteroids during the
study period. Nonetheless, this system also demonstrated fewer unscheduled visits to the
emergency department; higher peak expiratory flows at 4, 5, and 6 moths; higher FEV1 at 6
months; and better quality of life at 3 months after inclusion [48].
Compliance to new technologies is a relevant feature of telemedicine since not all of public
health systems can afford them, and there are still underprivileged groups who are not familiar
to these sorts of interventions. It seems that telemedicine for asthma is feasible, although when
compared to a web based self-management, patients presented higher rates of adherence to
the classic paper based strategies of self-control of symptoms and action plans, though other
critical feature such as lung function data was not reliable when the patient wrote it down on
his own [49].
In the pediatric population there is also lacking evidence of telemedicine benefit. Telemoni‐
toring of lung function on daily home spirometry in 44 children with professional feedback
did not reduce the frequency of exacerbations significantly when compared to conventional
treatment, nor the number of unscheduled visits, FEV1, quality of life or use of inhaled
corticosteroids [50]. This finding could be explained by the fact that a highly variable peak
expiratory flow and FEV1 values at time of symptoms and a complete overlap in distributions
between symptoms-free days and at times of symptoms [51], and also by the underpowered
nature of the study.
In conclusion, even though telemedicine for asthma seems to be a useful and promising tool
for empowering the asthmatic patients in order to guarantee the self-control of the disease, the
evidence of its benefit is still unclear. The short follow-ups, the heterogeneity of subjects and
the insufficient evidence of its cost-effectiveness, are paramount aspects that restrain the use
of telemedicine for asthmatic patients. We advocate for the tailoring treatment to the individual
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needs as the cornerstone of telehealthcare, although more studies are called for so the real effect
of this new technologies can be elucidated.]
4. Sleep-related breathing disorders and obstructive sleep apnea
Speaking of sleep-related breathing disorders, obstructive sleep apnea (OSA) is a prevalent
disease that affects approximately 6–7% of global population, although these figures probably
underestimate the real OSA prevalence. OSA is a sleep disorder in wich breathing repeatedly
stops and starts, which lead to hypoxemia, subsequent arousals, sleep fragmentation, thus, a
poor sleep quality in general. The main symptom is excessive daytime sleepiness, and is now
acknowledge as an independent cardiovascular risk factor, increasing the probability of
presenting hypertension, coronary artery disease, congestive cardiac failure, and stroke [52].
Attended full in-lab polysomnography (PSG) is the gold standard for OSA diagnosis, an
expensive test that demands plenty of time as well as fully trained technicians, and that is why
simplified sleep data recollection systems have been approved by the scientific societies for
patients with high or low pretest probability of OSA, in order to reduce the waiting list for
PSG [53]. Despite the increase of accredited sleep units, the demand of sleep studies has also
increased over the years considering the prevalence of the disease. Therefore, waiting lists
remain long [54]. Finally, continuous positive airway pressure (CPAP) is by far the recom‐
mended treatment for symptomatic or severe OSA, and it is known to reduce cardiovascular
death and non-fatal cardiovascular events [55], however, adherence to treatment has been a
troublesome factor in such a way that the first year of long-term treatment usually between 25
and 30% of patients drop out the device [56]. Having said this, there have been some efforts
to reduce the long waiting lists and increase the rates of CPAP adherence through telemedicine.
Regarding OSA diagnosis, the evidence of telemedicine usefulness is limited. So far, the
American Academy of Sleep Medicine has classified the sleep recording devices into four
categories. Full-attended in-lab PSG would be type 1; comprehensive portable unattended PSG
with a minimum of seven channels (including electroencephalogram, electrooculogram, chin
electromyogram, electrocardiogram or heart rate, airflow, respiratory effort, and oxygen
saturation) corresponds to type 2; type 3 comprises modified portable systems with a mini‐
mum of four channels monitored, including ventilation or airflow (at least two channels or
respiratory movement, or respiratory movement and airflow), heart rate or electrocardiogram,
and oxygen saturation comprise; and finally type 4 includes continuous single or dual
bioparameters with one or two channels, typically including oxygen saturation or airflow [57].
Despite the limitations of sensor losses that lead to technically inadequate recordings, the
inability to assess sleep time duration or the distinction of apneas (central or obstructive), and
the vast heterogeneity of sensors and recorders, the studies have confirmed the overall
usefulness of type 3 devices, especially if they focus on the outcome which results in earlier
access to treatment for the patient, specially those at high-risk of OSA. An alternative to type
3 devices is the home-polysomnography (H-PSG), which enables the home centered care for
patients and a complete sleep evaluation allowing the possibility of diagnosing a large panel
of sleep disorders. Thus, this H-PSG intends to perform as well as a full-attended PSG though
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in an unattended surrounding, without continuous supervision. A technician hooks-up the
device, and this factor limits the wide us of this technique [58]. Since the loss of data is still a
big issue with type 2 or 3 devices, potential future developments include the use of assistive
technology and telemedicine to allow real-time remote monitoring.
To enhance the quality of H-PSG signal, real-time telematics data transmission has been tested
generating successful and high-fidelity recordings through a cell phone for an easily deployed
home monitor device [59], and a failure rate of 11% of telemonitored in-hospital unattended
PSG compared to a 23% failure for unattended H-PSG was observed in another study [60].
Moreover, a pilot study, where 90% of recordings were of excellent quality, consisted in a
wireless device to obtain real-time remote supervision of H-PSG from the sleep lab [61]. With
this amount of evidence, it seems telemedicine for sleep studies recordings is feasible and may
be an important step to reduce the failure rates of home devices; however, there are important
barriers for implementing telemedicine for sleep studies regularly. Telemonitoring devices are
complex as well as their software; hence, incompatibility problems with other computer
programs should be expected. Furthermore, the cost-effectiveness of these systems is yet to be
determined considering the fact that the home must be equipped with a computer and Internet
connection, along with high specifications for computer programs. However, investigations
using integrated circuits available on the market (mobile telephony) have been conducted to
simplify access to these technologies [62]. Last but not least, there are also problems related to
privacy protection and security of medical data transmission [58]. An ongoing telehealth out-
of-laboratory “Fast Track for Sleep Apnea” program for veterans has been reported, that has
helped to relieve clinical load at the central sleep program, improved local access to sleep care,
and improved patient satisfaction with health care for sleep-related breathing disorders.
Nonetheless, the following challenges have been acknowledged so far: the programs needed
to be properly integrated with other data management systems and data storage devices must
be interfaced with computers attached to the VA server; data loss; and maintaining quality
control using metrics [63]. Either way, further research is required to determine the role of
telemedicine in sleep-related breathing disorders diagnosis, especially for OSA.
CPAP has shown to wipe out the adverse effect of severe OSA, especially those effects related
to cardiovascular diseases. However, the rates of adherence to CPAP are still far of being
acceptable. That is way any measure to achieve CPAP adherence is needed, and new ap‐
proaches such as telemedicine seems to be feasible and cost-effective. Compliance to CPAP is
a complex process that involves the participation of the device itself, family support, physi‐
cians, health care personal, sleep unit, and government politics [64]. So far, low-quality
evidence justifies the use of supportive interventions added to the usual clinical practice to
increase CPAP adherence [65] and, similar to previous items, more clinical trials are called for
to clear up the role of these interventions, where telemedicine is included. Earlier works
presented contradictory results. A statistically significant higher adherence was found in a
telemedicine-guided naïve to CPAP patients recently diagnosed with OSA along with greater
satisfaction, concluding that telehealth might be cost-effective for CPAP adherence manage‐
ment [66]; while no differences were found in hours of CPAP use, functional status or client
satisfaction in another study [67]. It is worth to mention that these two studies followed the
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patients for a 12-week and 30 days period, respectively. More recent clinical trials have added
some light to the subject. A 12-month telemedicine intervention resulted in a median CPAP
usage that was 0.9 h/night higher than that of an attention control group after 6 months, and
2.0 h/night higher after 12 months in a clinical trial including 250 patients, although the median
adherence of all patients was low, with 19% of patients refusing the use of CPAP at all [68].
Another clinical trial of 75 patients, showed higher rates of adherence to CPAP after 3 months
of telemedicine intervention, which was determined as a significant predictor of adherence,
apart from age and sleepiness symptoms measured by the Epworth Sleepiness Scale [69].
Finally, although no difference in hours of CPAP use was found in a study including 139 OSA
patients, telemedicine showed to be more cost-effective than the usual face-to-face manage‐
ment, with travel costs and lost work time being the most important sources of savings [70].
Improvement in case detection and the resulting higher healthcare demand has not been
accompanied by any real improvement in OSA management. In addition, health resources
assigned to OSA and its treatment have been found to be inadequate [71]. Telemedicine is an
appealing approach that needs to be explored and taken into consideration in order to obtain
a diagnosis and follow-up of sleep-related breathing disorders in a more timely fashion, which
would help to achieve the desirable management of these diseases.
5. Lung transplantation
[Lung transplantation is offered for a great variety on respiratory diseases that have reached
their end-stage, where no other treatment would obtain a reasonable survival. They are
complex patients who are in need of aggressive immunosuppressive treatment for a lifetime
that exposes them to opportunistic infections; so numerous complications are often taking
place. By far, the major problem for every lung transplant patient is the allograft dysfunction,
either acute or chronic (basically in its form of bronchiolitis obstructive syndrome). Allograft
dysfunction is characterized for a functional decline of the implant, which is usually measured
by FEV1 [72], and daily home spirometry has been shown to lead to earlier detection and
staging of bronchiolitis obstructive syndrome when compared with standard pulmonary
function testing [73]. Concerning the need of retrieving daily spirometric data, telemedicine
has been studied as a feasible instrument, making some interesting progress conducive to a
more efficient follow-up of patients and the prompt recognition of a possible complication.
Earlier works determined the telemonitored spirometry as feasible, valid, reliable, and
repeatable, when compared to the regular in-clinic functional testing [74–76]. Although these
studies were clearly underpowered due to the small samples included. While on earlier works
the objective is to determine the technical aspects of collecting acceptable spirometries, recent
works have carried out clinical trials to demonstrate that a computerized rule-based decision
support algorithm for nursing triage of potential acute bronchopulmonary events is effective
[72, 77], or the identification of these events taking decision rules developed using wavelet
analysis of declines in spirometry and increases in respiratory symptoms [78]. In conclusion,
the evidence of the increase of quality of life and reduction of hospital admissions seems fairly
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positive, though we are still in need of more studies [79] and the training process for both
medical staff and patients needs to be thorough [80] A different approach was revised by
another study where telemedicine was employed in a clinical trial for lung transplant candi‐
dates, and clinical outcome measures were monitoring adherence and level of communication
(for monitor acceptability and utilization), hospital length of stay after transplantation and
survival at 4 months. However, no significant differences in clinical outcomes between groups
were determined [81].
Similar to the previous three respiratory conditions, telemedicine for lung transplant patients
is feasible. Still and all, no cost-effectiveness has been demonstrated, thus, larger clinical trials
are required to establish the position of these new techniques in lung transplantation.
6. Conclusions
Telemedicine is a helpful tool to improve chronic respiratory patient management. Almost all
results shows reduction in Emergency visits and the number of hospitalizations but despite of
these results its implementation is troublesome and with different kind of factors relationship
with this slowly development. Most users report that the difficult to use the devices or
technology platform is the most important factor related to refuse telemedicine by users. We
need to work to improve its implementation through educational programs to healthcare
professionals and patients.
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